DCM Nouvelle Limited (DCMNVL) - Total Liabilities

Latest as of September 2025: Rs2.37 Billion INR ≈ $25.64 Million USD

Based on the latest financial reports, DCM Nouvelle Limited (DCMNVL) has total liabilities worth Rs2.37 Billion INR (≈ $25.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore DCM Nouvelle Limited (DCMNVL) equity growth momentum to track the company's year-over-year net asset growth rate.

DCM Nouvelle Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how DCM Nouvelle Limited's total liabilities have evolved over time, based on quarterly financial data. See DCM Nouvelle Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

DCM Nouvelle Limited Competitors by Total Liabilities

The table below lists competitors of DCM Nouvelle Limited ranked by their total liabilities.

Company Country Total Liabilities
Monks Investment Trust PLC
LSE:MNKS
UK GBX255.36 Million
Gold Strike Resources Corp.
V:GSR
Canada CA$73.73K
Bubang Co. Ltd
KQ:014470
Korea ₩81.19 Billion
KH Group Oyj
HE:KHG
Finland €115.60 Million
FiEE, Inc.
NASDAQ:FIEE
USA $2.94 Million
ML System S.A.
WAR:MLS
Poland zł393.10 Million
Ponni Sugars (Erode) Limited
NSE:PONNIERODE
India Rs837.70 Million
SP Systems Co.Ltd
KQ:317830
Korea ₩30.48 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down DCM Nouvelle Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DCM Nouvelle Limited stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.00 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DCM Nouvelle Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DCM Nouvelle Limited (2017–2025)

The table below shows the annual total liabilities of DCM Nouvelle Limited from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 Rs4.12 Billion
≈ $44.59 Million
-6.00%
2024-03-31 Rs4.39 Billion
≈ $47.43 Million
+36.81%
2023-03-31 Rs3.21 Billion
≈ $34.67 Million
+61.88%
2022-03-31 Rs1.98 Billion
≈ $21.42 Million
-3.46%
2021-03-31 Rs2.05 Billion
≈ $22.19 Million
-8.46%
2020-03-31 Rs2.24 Billion
≈ $24.23 Million
+25321029.94%
2019-03-31 Rs8.85K
≈ $95.71
-4.32%
2018-03-31 Rs9.25K
≈ $100.04
+7.25%
2017-03-31 Rs8.62K
≈ $93.28
--

About DCM Nouvelle Limited

NSE:DCMNVL India Textile Manufacturing
Market Cap
$30.30 Million
Rs2.80 Billion INR
Market Cap Rank
#23714 Global
#1303 in India
Share Price
Rs150.00
Change (1 day)
+0.15%
52-Week Range
Rs97.56 - Rs197.55
All Time High
Rs386.10
About

DCM Nouvelle Limited manufactures, exports, and sells cotton yarn in India, Bangladesh, China, Egypt, Guatemala, and internationally. It operates in two segments, Textiles and Chemicals. The company offers better cotton initiative, organic, and slub yarns under the PRIMERO, DINERO, and FUTURO brand names. It also offers specialty chemicals, such as benzylamine and dibenzylamine for use in various… Read more